<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37675986</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2050-084X</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2023</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>eLife</Title><ISOAbbreviation>Elife</ISOAbbreviation></Journal><ArticleTitle>Translation of dipeptide repeat proteins in <i>C9ORF72</i> ALS/FTD through unique and redundant AUG initiation codons.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e83189</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7554/eLife.83189</ELocationID><Abstract><AbstractText>A hexanucleotide repeat expansion in <i>C9ORF72</i> is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). A hallmark of ALS/FTD pathology is the presence of dipeptide repeat (DPR) proteins, produced from both sense GGGGCC (poly-GA, poly-GP, poly-GR) and antisense CCCCGG (poly-PR, poly-PG, poly-PA) transcripts. Translation of sense DPRs, such as poly-GA and poly-GR, depends on non-canonical (non-AUG) initiation codons. Here, we provide evidence for canonical AUG-dependent translation of two antisense DPRs, poly-PR and poly-PG. A single AUG is required for synthesis of poly-PR, one of the most toxic DPRs. Unexpectedly, we found redundancy between three AUG codons necessary for poly-PG translation. Further, the eukaryotic translation initiation factor 2D (EIF2D), which was previously implicated in sense DPR synthesis, is not required for AUG-dependent poly-PR or poly-PG translation, suggesting that distinct translation initiation factors control DPR synthesis from sense and antisense transcripts. Our findings on DPR synthesis from the <i>C9ORF72</i> locus may be broadly applicable to many other nucleotide repeat expansion disorders.</AbstractText><CopyrightInformation>&#xa9; 2023, Sonobe et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sonobe</LastName><ForeName>Yoshifumi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University of Chicago Medical Center, Chicago, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Chicago Medical Center, Chicago, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Chicago, Chicago, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Soojin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Chan Medical School, Worcester, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnan</LastName><ForeName>Gopinath</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Chan Medical School, Worcester, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Yuanzheng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Neuromuscular &amp; Movement Disorders, Biogen, Cambridge, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Deborah Y</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Neuromuscular &amp; Movement Disorders, Biogen, Cambridge, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Fen-Biao</ForeName><Initials>FB</Initials><AffiliationInfo><Affiliation>RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Chan Medical School, Worcester, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Roos</LastName><ForeName>Raymond P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>University of Chicago Medical Center, Chicago, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Chicago Medical Center, Chicago, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Chicago, Chicago, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kratsios</LastName><ForeName>Paschalis</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1363-9271</Identifier><AffiliationInfo><Affiliation>Neuroscience Institute, University of Chicago, Chicago, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology, University of Chicago, Chicago, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS101986</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 NS057553</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Elife</MedlineTA><NlmUniqueID>101579614</NlmUniqueID><ISSNLinking>2050-084X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018387">Codon, Initiator</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>doi: 10.1101/2022.08.06.503063</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="Y">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018387" MajorTopicYN="N">Codon, Initiator</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020774" MajorTopicYN="Y">Pick Disease of the Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AUG initiation codons</Keyword><Keyword MajorTopicYN="N">C9ORF72</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">dipeptide protein repeats</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">genomics</Keyword><Keyword MajorTopicYN="N">human</Keyword><Keyword MajorTopicYN="N">iPSC-derived neurons</Keyword><Keyword MajorTopicYN="N">mouse</Keyword><Keyword MajorTopicYN="N">neuroscience</Keyword></KeywordList><CoiStatement>YS, SL, GK, FG, RR No competing interests declared, YG, DK affiliated with Biogen. The authors have no financial interests to declare, PK Reviewing editor, eLife</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>8</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37675986</ArticleId><ArticleId IdType="pmc">PMC10541178</ArticleId><ArticleId IdType="doi">10.7554/eLife.83189</ArticleId><ArticleId IdType="pii">83189</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Almeida S, Gascon E, Tran H, Chou HJ, Gendron TF, Degroot S, Tapper AR, Sellier C, Charlet-Berguerand N, Karydas A, Seeley WW, Boxer AL, Petrucelli L, Miller BL, Gao F-B. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathologica. 2013;126:385&#x2013;399. doi: 10.1007/s00401-013-1149-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1149-y</ArticleId><ArticleId IdType="pmc">PMC3753484</ArticleId><ArticleId IdType="pubmed">23836290</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S, Krishnan G, Rushe M, Gu Y, Kankel MW, Gao F-B. Production of poly(GA) in C9ORF72 patient motor neurons derived from induced pluripotent stem cells. Acta Neuropathologica. 2019;138:1099&#x2013;1101. doi: 10.1007/s00401-019-02083-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02083-z</ArticleId><ArticleId IdType="pmc">PMC6851345</ArticleId><ArticleId IdType="pubmed">31624870</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayhan F, Perez BA, Shorrock HK, Zu T, Banez-Coronel M, Reid T, Furuya H, Clark HB, Troncoso JC, Ross CA, Subramony SH, Ashizawa T, Wang ET, Yachnis AT, Ranum LP. SCA8 RAN polySer protein preferentially accumulates in white matter regions and is regulated by eIF3F. The EMBO Journal. 2018;37:e99023. doi: 10.15252/embj.201899023.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201899023</ArticleId><ArticleId IdType="pmc">PMC6166133</ArticleId><ArticleId IdType="pubmed">30206144</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee P, Mehta AR, Nirujogi RS, Cooper J, James OG, Nanda J, Longden J, Burr K, McDade K, Salzinger A, Paza E, Newton J, Story D, Pal S, Smith C, Alessi DR, Selvaraj BT, Priller J, Chandran S. Cell-autonomous immune dysfunction driven by disrupted autophagy in C9orf72-ALS iPSC-derived microglia contributes to neurodegeneration. Science Advances. 2023;9:eabq0651. doi: 10.1126/sciadv.abq0651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abq0651</ArticleId><ArticleId IdType="pmc">PMC10121169</ArticleId><ArticleId IdType="pubmed">37083530</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin M, Pfister V, Gaucherot A, Ruffenach F, Negroni L, Sellier C, Charlet-Berguerand N. Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. The EMBO Journal. 2020;39:e100574. doi: 10.15252/embj.2018100574.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2018100574</ArticleId><ArticleId IdType="pmc">PMC7024836</ArticleId><ArticleId IdType="pubmed">31930538</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W, Wang S, Mestre AA, Fu C, Makarem A, Xian F, Hayes LR, Lopez-Gonzalez R, Drenner K, Jiang J, Cleveland DW, Sun S. C9ORF72 GGGGCC repeat-associated non-AUG translation is upregulated by stress through eIF2&#x3b1; phosphorylation. Nature Communications. 2018;9:51. doi: 10.1038/s41467-017-02495-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02495-z</ArticleId><ArticleId IdType="pmc">PMC5754368</ArticleId><ArticleId IdType="pubmed">29302060</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W, Wang S, Zhang Z, Morgens DW, Hayes LR, Lee S, Portz B, Xie Y, Nguyen BV, Haney MS, Yan S, Dong D, Coyne AN, Yang J, Xian F, Cleveland DW, Qiu Z, Rothstein JD, Shorter J, Gao F-B, Bassik MC, Sun S. CRISPR-Cas9 screens identify the RNA Helicase DDX3X as a repressor of C9ORF72 (GGGGCC)n repeat-associated non-AUG translation. Neuron. 2019;104:885&#x2013;898. doi: 10.1016/j.neuron.2019.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.09.003</ArticleId><ArticleId IdType="pmc">PMC6895427</ArticleId><ArticleId IdType="pubmed">31587919</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J, Cook C, Gendron TF, Jansen-West K, Del Rosso G, Daughrity LM, Castanedes-Casey M, Kurti A, Stankowski JN, Disney MD, Rothstein JD, Dickson DW, Fryer JD, Zhang Y-J, Petrucelli L. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Molecular Neurodegeneration. 2019;14:9. doi: 10.1186/s13024-019-0310-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0310-z</ArticleId><ArticleId IdType="pmc">PMC6377782</ArticleId><ArticleId IdType="pubmed">30767771</ArticleId></ArticleIdList></Reference><Reference><Citation>Chintalaphani SR, Pineda SS, Deveson IW, Kumar KR. An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics. Acta Neuropathologica Communications. 2021;9:98. doi: 10.1186/s40478-021-01201-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01201-x</ArticleId><ArticleId IdType="pmc">PMC8145836</ArticleId><ArticleId IdType="pubmed">34034831</ArticleId></ArticleIdList></Reference><Reference><Citation>Dane TL, Gill AL, Vieira FG, Denton KR. Reduced C9orf72 expression exacerbates polyGR toxicity in patient iPSC-derived motor neurons and a Type I protein arginine methyltransferase inhibitor reduces that toxicity. Frontiers in Cellular Neuroscience. 2023;17:1134090. doi: 10.3389/fncel.2023.1134090.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2023.1134090</ArticleId><ArticleId IdType="pmc">PMC10149854</ArticleId><ArticleId IdType="pubmed">37138766</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung G-YR, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Depienne C, Mandel JL. 30 years of repeat expansion disorders: What have we learned and what are the remaining challenges? American Journal of Human Genetics. 2021;108:764&#x2013;785. doi: 10.1016/j.ajhg.2021.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2021.03.011</ArticleId><ArticleId IdType="pmc">PMC8205997</ArticleId><ArticleId IdType="pubmed">33811808</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Lu Y, Lopez-Gonzalez R, Kim NC, Almeida S, Lee K-H, Badders N, Valentine M, Miller BL, Wong PC, Petrucelli L, Kim HJ, Gao F-B, Taylor JP. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao FB, Richter JD, Cleveland DW. Rethinking unconventional translation in neurodegeneration. Cell. 2017;171:994&#x2013;1000. doi: 10.1016/j.cell.2017.10.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.10.042</ArticleId><ArticleId IdType="pmc">PMC5728172</ArticleId><ArticleId IdType="pubmed">29149615</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Bieniek KF, Zhang Y-J, Jansen-West K, Ash PEA, Caulfield T, Daughrity L, Dunmore JH, Castanedes-Casey M, Chew J, Cosio DM, van Blitterswijk M, Lee WC, Rademakers R, Boylan KB, Dickson DW, Petrucelli L. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathologica. 2013;126:829&#x2013;844. doi: 10.1007/s00401-013-1192-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Chew J, Stankowski JN, Hayes LR, Zhang Y-J, Prudencio M, Carlomagno Y, Daughrity LM, Jansen-West K, Perkerson EA, O&#x2019;Raw A, Cook C, Pregent L, Belzil V, van Blitterswijk M, Tabassian LJ, Lee CW, Yue M, Tong J, Song Y, Castanedes-Casey M, Rousseau L, Phillips V, Dickson DW, Rademakers R, Fryer JD, Rush BK, Pedraza O, Caputo AM, Desaro P, Palmucci C, Robertson A, Heckman MG, Diehl NN, Wiggs E, Tierney M, Braun L, Farren J, Lacomis D, Ladha S, Fournier CN, McCluskey LF, Elman LB, Toledo JB, McBride JD, Tiloca C, Morelli C, Poletti B, Solca F, Prelle A, Wuu J, Jockel-Balsarotti J, Rigo F, Ambrose C, Datta A, Yang W, Raitcheva D, Antognetti G, McCampbell A, Van Swieten JC, Miller BL, Boxer AL, Brown RH, Bowser R, Miller TM, Trojanowski JQ, Grossman M, Berry JD, Hu WT, Ratti A, Traynor BJ, Disney MD, Benatar M, Silani V, Glass JD, Floeter MK, Rothstein JD, Boylan KB, Petrucelli L. Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis. Science Translational Medicine. 2017;9:eaai7866. doi: 10.1126/scitranslmed.aai7866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aai7866</ArticleId><ArticleId IdType="pmc">PMC5576451</ArticleId><ArticleId IdType="pubmed">28356511</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleason AC, Ghadge G, Chen J, Sonobe Y, Roos RP. Machine learning predicts translation initiation sites in neurologic diseases with nucleotide repeat expansions. PLOS ONE. 2022;17:e0256411. doi: 10.1371/journal.pone.0256411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0256411</ArticleId><ArticleId IdType="pmc">PMC9159584</ArticleId><ArticleId IdType="pubmed">35648796</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman LD, Prudencio M, Srinivasan AR, Rifai OM, Lee VM-Y, Petrucelli L, Bonini NM. eIF4B and eIF4H mediate GR production from expanded G4C2 in a Drosophila model for C9orf72-associated ALS. Acta Neuropathologica Communications. 2019;7:62. doi: 10.1186/s40478-019-0711-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0711-9</ArticleId><ArticleId IdType="pmc">PMC6485101</ArticleId><ArticleId IdType="pubmed">31023341</ArticleId></ArticleIdList></Reference><Reference><Citation>Green KM, Glineburg MR, Kearse MG, Flores BN, Linsalata AE, Fedak SJ, Goldstrohm AC, Barmada SJ, Todd PK. RAN translation at C9orf72-associated repeat expansions is selectively enhanced by the integrated stress response. Nature Communications. 2017;8:2005. doi: 10.1038/s41467-017-02200-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02200-0</ArticleId><ArticleId IdType="pmc">PMC5722904</ArticleId><ArticleId IdType="pubmed">29222490</ArticleId></ArticleIdList></Reference><Reference><Citation>Green KM, Miller SL, Malik I, Todd PK. Non-canonical initiation factors modulate repeat-associated non-AUG translation. Human Molecular Genetics. 2022;31:2521&#x2013;2534. doi: 10.1093/hmg/ddac021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddac021</ArticleId><ArticleId IdType="pmc">PMC9618161</ArticleId><ArticleId IdType="pubmed">35220421</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Z, Liu L, Tao Z, Wang R, Ren H, Sun H, Lin Z, Zhang Z, Mu C, Zhou J, Wang G. Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR. Nature Communications. 2019;10:2906. doi: 10.1038/s41467-019-10956-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10956-w</ArticleId><ArticleId IdType="pmc">PMC6606620</ArticleId><ArticleId IdType="pubmed">31266945</ArticleId></ArticleIdList></Reference><Reference><Citation>Janes KA. An analysis of critical factors for quantitative immunoblotting. Science Signaling. 2015;8:rs2. doi: 10.1126/scisignal.2005966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2005966</ArticleId><ArticleId IdType="pmc">PMC4401487</ArticleId><ArticleId IdType="pubmed">25852189</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M, Blokhuis AM, Westeneng H-J, Terpstra ML, Zundel CAC, Vieira de S&#xe1; R, Schellevis RD, Waite AJ, Blake DJ, Veldink JH, van den Berg LH, Pasterkamp RJ. C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Annals of Neurology. 2015;78:426&#x2013;438. doi: 10.1002/ana.24453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24453</ArticleId><ArticleId IdType="pmc">PMC4744979</ArticleId><ArticleId IdType="pubmed">26044557</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer NJ, Carlomagno Y, Zhang YJ, Almeida S, Cook CN, Gendron TF, Prudencio M, Van Blitterswijk M, Belzil V, Couthouis J, Paul JW, Goodman LD, Daughrity L, Chew J, Garrett A, Pregent L, Jansen-West K, Tabassian LJ, Rademakers R, Boylan K, Graff-Radford NR, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Boeve BF, Deng N, Feng Y, Cheng TH, Dickson DW, Cohen SN, Bonini NM, Link CD, Gao FB, Petrucelli L, Gitler AD. Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts. Science. 2016;353:708&#x2013;712. doi: 10.1126/science.aaf7791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf7791</ArticleId><ArticleId IdType="pmc">PMC5823025</ArticleId><ArticleId IdType="pubmed">27516603</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan G, Raitcheva D, Bartlett D, Prudencio M, McKenna-Yasek DM, Douthwright C, Oskarsson BE, Ladha S, King OD, Barmada SJ, Miller TM, Bowser R, Watts JK, Petrucelli L, Brown RH, Kankel MW, Gao F-B. Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD. Nature Communications. 2022;13:2799. doi: 10.1038/s41467-022-30387-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30387-4</ArticleId><ArticleId IdType="pmc">PMC9119980</ArticleId><ArticleId IdType="pubmed">35589711</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I, Xiang S, Kato M, Wu L, Theodoropoulos P, Wang T, Kim J, Yun J, Xie Y, McKnight SL. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science. 2014;345:1139&#x2013;1145. doi: 10.1126/science.1254917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1254917</ArticleId><ArticleId IdType="pmc">PMC4459787</ArticleId><ArticleId IdType="pubmed">25081482</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampasona A, Almeida S, Gao FB. Translation of the poly(GR) frame in C9ORF72-ALS/FTD is regulated by cis-elements involved in alternative splicing. Neurobiology of Aging. 2021;105:327&#x2013;332. doi: 10.1016/j.neurobiolaging.2021.04.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2021.04.030</ArticleId><ArticleId IdType="pmc">PMC8338774</ArticleId><ArticleId IdType="pubmed">34157654</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K-H, Zhang P, Kim HJ, Mitrea DM, Sarkar M, Freibaum BD, Cika J, Coughlin M, Messing J, Molliex A, Maxwell BA, Kim NC, Temirov J, Moore J, Kolaitis R-M, Shaw TI, Bai B, Peng J, Kriwacki RW, Taylor JP. C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell. 2016;167:774&#x2013;788. doi: 10.1016/j.cell.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmer C, Oeckl P, Weishaupt JH, Volk AE, Diehl-Schmid J, Schroeter ML, Lauer M, Kornhuber J, Levin J, Fassbender K, Landwehrmeyer B, German Consortium for Frontotemporal Lobar Degeneration. Schludi MH, Arzberger T, Kremmer E, Flatley A, Feederle R, Steinacker P, Weydt P, Ludolph AC, Edbauer D, Otto M. Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD. EMBO Molecular Medicine. 2017;9:859&#x2013;868. doi: 10.15252/emmm.201607486.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201607486</ArticleId><ArticleId IdType="pmc">PMC5494528</ArticleId><ArticleId IdType="pubmed">28408402</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Mori E, Kato M, Xiang S, Wu L, Kwon I, McKnight SL. Toxic PR Poly-Dipeptides encoded by the C9orf72 repeat expansion target LC domain polymers. Cell. 2016;167:789&#x2013;802. doi: 10.1016/j.cell.2016.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.003</ArticleId><ArticleId IdType="pmc">PMC5076566</ArticleId><ArticleId IdType="pubmed">27768897</ArticleId></ArticleIdList></Reference><Reference><Citation>Linsalata AE, He F, Malik AM, Glineburg MR, Green KM, Natla S, Flores BN, Krans A, Archbold HC, Fedak SJ, Barmada SJ, Todd PK. DDX3X and specific initiation factors modulate FMR1 repeat-associated non-AUG-initiated translation. EMBO Reports. 2019;20:e47498. doi: 10.15252/embr.201847498.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201847498</ArticleId><ArticleId IdType="pmc">PMC6726903</ArticleId><ArticleId IdType="pubmed">31347257</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Andreucci A, Iwamoto N, Yin Y, Yang H, Liu F, Bulychev A, Hu XS, Lin X, Lamore S, Patil S, Mohapatra S, Purcell-Estabrook E, Taborn K, Dale E, Vargeese C. Preclinical evaluation of WVE-004, aninvestigational stereopure oligonucleotide forthe treatment of C9orf72-associated ALS or FTD. Molecular Therapy. Nucleic Acids. 2022a;28:558&#x2013;570. doi: 10.1016/j.omtn.2022.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2022.04.007</ArticleId><ArticleId IdType="pmc">PMC9092894</ArticleId><ArticleId IdType="pubmed">35592494</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Xing H, Ernst AF, Liu C, Maugee C, Yokoi F, Lakshmana M, Li Y. Hyperactivity of Purkinje cell and motor deficits in C9orf72 knockout mice. Molecular and Cellular Neurosciences. 2022b;121:103756. doi: 10.1016/j.mcn.2022.103756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2022.103756</ArticleId><ArticleId IdType="pmc">PMC10369482</ArticleId><ArticleId IdType="pubmed">35843530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, Lu Y, Gendron TF, Karydas A, Tran H, Yang D, Petrucelli L, Miller BL, Almeida S, Gao F-B. Poly(GR) in C9ORF72-Related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron. 2016;92:383&#x2013;391. doi: 10.1016/j.neuron.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, Yang D, Pribadi M, Kim TS, Krishnan G, Choi SY, Lee S, Coppola G, Gao F-B. Partial inhibition of the overactivated Ku80-dependent DNA repair pathway rescues neurodegeneration in C9ORF72-ALS/FTD. PNAS. 2019;116:9628&#x2013;9633. doi: 10.1073/pnas.1901313116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1901313116</ArticleId><ArticleId IdType="pmc">PMC6511021</ArticleId><ArticleId IdType="pubmed">31019093</ArticleId></ArticleIdList></Reference><Reference><Citation>Loveland AB, Svidritskiy E, Susorov D, Lee S, Park A, Zvornicanin S, Demo G, Gao F-B, Korostelev AA. Ribosome inhibition by C9ORF72-ALS/FTD-associated poly-PR and poly-GR proteins revealed by cryo-EM. Nature Communications. 2022;13:2776. doi: 10.1038/s41467-022-30418-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30418-0</ArticleId><ArticleId IdType="pmc">PMC9120013</ArticleId><ArticleId IdType="pubmed">35589706</ArticleId></ArticleIdList></Reference><Reference><Citation>Maor-Nof M, Shipony Z, Lopez-Gonzalez R, Nakayama L, Zhang Y-J, Couthouis J, Blum JA, Castruita PA, Linares GR, Ruan K, Ramaswami G, Simon DJ, Nof A, Santana M, Han K, Sinnott-Armstrong N, Bassik MC, Geschwind DH, Tessier-Lavigne M, Attardi LD, Lloyd TE, Ichida JK, Gao F-B, Greenleaf WJ, Yokoyama JS, Petrucelli L, Gitler AD. p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR) Cell. 2021;184:689&#x2013;708. doi: 10.1016/j.cell.2020.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7886018</ArticleId><ArticleId IdType="pubmed">33482083</ArticleId></ArticleIdList></Reference><Reference><Citation>McEachin ZT, Parameswaran J, Raj N, Bassell GJ, Jiang J. RNA-mediated toxicity in C9orf72 ALS and FTD. Neurobiology of Disease. 2020;145:105055. doi: 10.1016/j.nbd.2020.105055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105055</ArticleId><ArticleId IdType="pmc">PMC7572710</ArticleId><ArticleId IdType="pubmed">32829028</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, Gr&#xf6;nke S, Niccoli T, Ridler CE, Clayton EL, Devoy A, Moens T, Norona FE, Woollacott IOC, Pietrzyk J, Cleverley K, Nicoll AJ, Pickering-Brown S, Dols J, Cabecinha M, Hendrich O, Fratta P, Fisher EMC, Partridge L, Isaacs AM. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345:1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Parameswaran J, Zhang N, Tilahun K, Pant DC, Chilukuri G, Asress S, Banerjee A, Davis E, Schwartz SL, Conn GL, Bassell GJ, Jiang J. Antisense, but Not Sense, Repeat Expanded RNAs Activate PKR/eIF2&#x3b1;-Dependent Integrated Stress Response in C9orf72 FTD/ALS. bioRxiv. 2022 doi: 10.1101/2022.06.06.495030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.06.495030</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Lee J, Kim J-H, Lee J, Park H, Lim C. ZNF598 co-translationally titrates poly(GR) protein implicated in the pathogenesis of C9ORF72-associated ALS/FTD. Nucleic Acids Research. 2021;49:11294&#x2013;11311. doi: 10.1093/nar/gkab834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab834</ArticleId><ArticleId IdType="pmc">PMC8565315</ArticleId><ArticleId IdType="pubmed">34551427</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Sim&#xf3;n-S&#xe1;nchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita V-M, Kaivorinne A-L, H&#xf6;ltt&#xe4;-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chi&#xf2; A, Restagno G, Borghero G, Sabatelli M, ITALSGEN Consortium. Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter JD, Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature. 2005;433:477&#x2013;480. doi: 10.1038/nature03205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03205</ArticleId><ArticleId IdType="pubmed">15690031</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudich P, Snoznik C, Watkins SC, Monaghan J, Pandey UB, Lamitina ST. Nuclear localized C9orf72-associated arginine-containing dipeptides exhibit age-dependent toxicity in C. elegans. Human Molecular Genetics. 2017;26:4916&#x2013;4928. doi: 10.1093/hmg/ddx372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx372</ArticleId><ArticleId IdType="pmc">PMC5886095</ArticleId><ArticleId IdType="pubmed">29036691</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz A, Pinheiro Marques J, Oertig I, Maharjan N, Saxena S. Emerging perspectives on Dipeptide repeat proteins in C9ORF72 ALS/FTD. Frontiers in Cellular Neuroscience. 2021;15:637548. doi: 10.3389/fncel.2021.637548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.637548</ArticleId><ArticleId IdType="pmc">PMC7930069</ArticleId><ArticleId IdType="pubmed">33679328</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonobe Y, Ghadge G, Masaki K, Sendoel A, Fuchs E, Roos RP. Translation of dipeptide repeat proteins from the C9ORF72 expanded repeat is associated with cellular stress. Neurobiology of Disease. 2018;116:155&#x2013;165. doi: 10.1016/j.nbd.2018.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.05.009</ArticleId><ArticleId IdType="pmc">PMC6331062</ArticleId><ArticleId IdType="pubmed">29792928</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonobe Y, Aburas J, Krishnan G, Fleming AC, Ghadge G, Islam P, Warren EC, Gu Y, Kankel MW, Brown AEX, Kiskinis E, Gendron TF, Gao F-B, Roos RP, Kratsios P. A C. elegans model of C9orf72-associated ALS/FTD uncovers A conserved role for eIF2D in RAN translation. Nature Communications. 2021;12:6025. doi: 10.1038/s41467-021-26303-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26303-x</ArticleId><ArticleId IdType="pmc">PMC8519953</ArticleId><ArticleId IdType="pubmed">34654821</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabet R, Schaeffer L, Freyermuth F, Jambeau M, Workman M, Lee C-Z, Lin C-C, Jiang J, Jansen-West K, Abou-Hamdan H, D&#xe9;saubry L, Gendron T, Petrucelli L, Martin F, Lagier-Tourenne C. CUG initiation and frameshifting enable production of dipeptide repeat proteins from ALS/FTD C9ORF72 transcripts. Nature Communications. 2018;9:152. doi: 10.1038/s41467-017-02643-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02643-5</ArticleId><ArticleId IdType="pmc">PMC5764992</ArticleId><ArticleId IdType="pubmed">29323119</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran H, Moazami MP, Yang H, McKenna-Yasek D, Douthwright CL, Pinto C, Metterville J, Shin M, Sanil N, Dooley C, Puri A, Weiss A, Wightman N, Gray-Edwards H, Marosfoi M, King RM, Kenderdine T, Fabris D, Bowser R, Watts JK, Brown RH. Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide. Nature Medicine. 2022;28:117&#x2013;124. doi: 10.1038/s41591-021-01557-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01557-6</ArticleId><ArticleId IdType="pmc">PMC8861976</ArticleId><ArticleId IdType="pubmed">34949835</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng Y-J, Sandwith SN, Green KM, Chambers AE, Krans A, Raimer HM, Sharlow ME, Reisinger MA, Richardson AE, Routh ED, Smaldino MA, Wang Y-H, Vaughn JP, Todd PK, Smaldino PJ. The RNA helicase DHX36-G4R1 modulates C9orf72 GGGGCC hexanucleotide repeat-associated translation. The Journal of Biological Chemistry. 2021;297:100914. doi: 10.1016/j.jbc.2021.100914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100914</ArticleId><ArticleId IdType="pmc">PMC8326427</ArticleId><ArticleId IdType="pubmed">34174288</ArticleId></ArticleIdList></Reference><Reference><Citation>van &#x2018;t Spijker HM, Stackpole EE, Almeida S, Katsara O, Liu B, Shen K, Schneider RJ, Gao F-B, Richter JD. Ribosome profiling reveals novel regulation of C9ORF72 GGGGCC repeat-containing RNA translation. RNA. 2022;28:123&#x2013;138. doi: 10.1261/rna.078963.121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.078963.121</ArticleId><ArticleId IdType="pmc">PMC8906550</ArticleId><ArticleId IdType="pubmed">34848561</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Tan W, Westergard T, Krishnamurthy K, Markandaiah SS, Shi Y, Lin S, Shneider NA, Monaghan J, Pandey UB, Pasinelli P, Ichida JK, Trotti D. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron. 2014;84:1213&#x2013;1225. doi: 10.1016/j.neuron.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada SB, Gendron TF, Niccoli T, Genuth NR, Grosely R, Shi Y, Glaria I, Kramer NJ, Nakayama L, Fang S, Dinger TJI, Thoeng A, Rocha G, Barna M, Puglisi JD, Partridge L, Ichida JK, Isaacs AM, Petrucelli L, Gitler AD. RPS25 is required for efficient RAN translation of C9orf72 and other neurodegenerative disease-associated nucleotide repeats. Nature Neuroscience. 2019;22:1383&#x2013;1388. doi: 10.1038/s41593-019-0455-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0455-7</ArticleId><ArticleId IdType="pmc">PMC6713615</ArticleId><ArticleId IdType="pubmed">31358992</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y-J, Guo L, Gonzales PK, Gendron TF, Wu Y, Jansen-West K, O&#x2019;Raw AD, Pickles SR, Prudencio M, Carlomagno Y, Gachechiladze MA, Ludwig C, Tian R, Chew J, DeTure M, Lin W-L, Tong J, Daughrity LM, Yue M, Song Y, Andersen JW, Castanedes-Casey M, Kurti A, Datta A, Antognetti G, McCampbell A, Rademakers R, Oskarsson B, Dickson DW, Kampmann M, Ward ME, Fryer JD, Link CD, Shorter J, Petrucelli L. Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity. Science. 2019;363:eaav2606. doi: 10.1126/science.aav2606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav2606</ArticleId><ArticleId IdType="pmc">PMC6524780</ArticleId><ArticleId IdType="pubmed">30765536</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Jiang J, Gendron TF, McAlonis-Downes M, Jiang L, Taylor A, Diaz Garcia S, Ghosh Dastidar S, Rodriguez MJ, King P, Zhang Y, La Spada AR, Xu H, Petrucelli L, Ravits J, Da Cruz S, Lagier-Tourenne C, Cleveland DW. Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9ORF72. Nature Neuroscience. 2020;23:615&#x2013;624. doi: 10.1038/s41593-020-0619-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0619-5</ArticleId><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, Liu Y, Ba&#xf1;ez-Coronel M, Reid T, Pletnikova O, Lewis J, Miller TM, Harms MB, Falchook AE, Subramony SH, Ostrow LW, Rothstein JD, Troncoso JC, Ranum LPW. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. PNAS. 2013;110:E4968&#x2013;E4977. doi: 10.1073/pnas.1315438110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1315438110</ArticleId><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>